Strategic Program Cancer nieuws
Strategic Program Cancer nieuws
New partnership accelerates the development of new cancer therapies
Cancer is one of the greatest health challenges of our time. We still do not succeed in providing effective treatment to all cancer patients. Oncode Accelerator now aims to change this. Within this partnership, more than 30 public and private partners, including UMC Utrecht, are now working together. Its aim: to make patients benefit from effective therapies faster.
Read moreHow do immune cells recognise cancer?
UMC Utrecht unravels how immune cells recognise and battle cancer.
Read moreAI foresees higher risk of breast cancer
Women with dense breast tissue are more likely to develop breast cancer. With the help of AI (artificial intelligence), researchers from UMC Utrecht have now found a factor that may be an additional indicator that cancer is developing within dense breasts: the extent to which the normal glandular tissue lights up on the MRI because of the contrast fluid. This result may ultimately help to more effectively use additional MRI scans to detect cancer in dense breast tissue.
Read moreMarcel Kool appointed Professor of Childhood brain tumors
Prof. dr. Marcel Kool has been appointed professor of Childhood brain tumors at UMC Utrecht. With his professorship, he aims to accelerate developments in precision medicine: 'Together we can ensure that knowledge from the lab is translated more quickly into clinical studies for the children who stand to benefit the most.'
Read moreLeendert Looijenga becomes professor
Leendert Looijenga has been appointed professor of translational germ cell oncology and fertility at UMC Utrecht. With his chair, he aims to improve the diagnosis and follow-up of children and young adults with germ cell tumours to contribute to improved survival and quality of life.
Read moreRonald de Krijger becomes professor of pathology
Ronald de Krijger has been appointed professor of Pathology of solid pediatric tumours at UMC Utrecht.
Read moreNew UMC Utrecht cancer research with 'mini-organs'
New UMC Utrecht cancer research with 'mini-organs'.
Read moreUMC Utrecht makes genetic testing more accessible
Is my breast or ovarian cancer hereditary? To answer that question, patients are referred to the genetics department of a university medical centre. But that referral does not always take place or takes place relatively late. UMC Utrecht therefore trained healthcare professionals from eight hospitals to request genetic testing themselves. As a result, patients receive genetic testing faster.
Read moreUMC Utrecht eases treatment of liver cancer
Treated in two hours instead of two weeks: the go-ahead has been given for two clinical trials in which liver cancer patients will actually be treated with the hybrid C-arm. The device, an invention of UMC Utrecht, speeds up and eases radioembolization. This project is part of the IMAGIO consortium, which has now received an IHI grant of no less than 24 million euros from the European Union and its partners.
Read moreNew cancer research with MR-Linac and ultrasound
UMC Utrecht researchers are starting two new projects to treat cancer with image-guided interventions. For one research, they are using MRI-guided radiotherapy, for the other ultrasound techniques. Their projects are made possible by KWF Dutch Cancer Society, which has granted them almost 1.5 million euros in total.
Read more